Crohns Disease Therapeutics Market Scope And Analysis

Crohn's Disease Therapeutics Market Report Scope

Industry Developments and Future Opportunities:

The Crohn's disease therapeutics market forecast is estimated on the basis of various secondary and primary research findings, such as key company publications, association data, and databases. As per the company press releases, key developments by major players operating in the Crohn's disease therapeutics market are listed below:

• In 2023, the US Food and Drug Administration (FDA) approved the first oral pill—Rinvoq (upadacitinib)—to treat moderate-to-severe Crohn's disease. Rinvoq is meant to treat adult patients who could not be treated successfully with drug candidates blocking tumor necrosis factor (TNF).
• In 2022, the FDA approved Skyrizi for the treatment of adults with moderate-to-severe active Crohn's disease cases.
• In 2021, AbbVie Inc. announced the initiation of the Phase 3 trial of risankizumab for the treatment of Crohn's disease. Risankizumab is a humanized monoclonal antibody that selectively targets the interleukin-23 (IL-23) pathway. The trial is aimed at evaluating the efficacy and safety of risankizumab in patients with moderate-to-severe Crohn's disease.
• In 2021, Takeda Pharmaceutical Company Limited announced the initiation of the Phase 3 trial of the oral compound TAK-721 for the treatment of Crohn's disease. TAK-721 is a selective antagonist of the chemokine receptor CXCR3. The trial is aimed at evaluating the efficacy and safety of TAK-721 in patients with moderate-to-severe Crohn's disease.

Competitive Landscape and Key Companies:

Abbvie, Inc.; Johnson and Johnson Private Limited; GlaxoSmithKline Plc; Merck and Co., Inc.; Novartis Ag; Celgene Corporation; Genentech; Pfizer Inc.; Nestle Health Science; and Boehringer Ingelheim GmbH are among the prominent players profiled in the Crohn's disease therapeutics market report. In addition, several other players have been studied and analyzed during the study to get a holistic view of the market and its ecosystem. These companies focus on geographic expansions and new product launches to meet the growing demand from consumers worldwide and expand their product range with specialty portfolios. Their global presence allows them to serve a large customer base, subsequently facilitating market expansion.